SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II–III Diffuse Gliomas

SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II–III Diffuse Gliomas

Background: Diffuse gliomas, grades II and III, hereafter called lower-grade gliomas (LGG), have variable, difficult to predict clinical courses, resulting in multiple studies to identify prognostic biomarkers. The purpose of this study was to assess expression or methylation of the homeobox family...

Full description

Bibliographic Details
Main Authors: Yu-An Zhang, Yunyun Zhou, Xin Luo, Kai Song, Xiaotu Ma, Adwait Sathe, Luc Girard, Guanghua Xiao, Adi F Gazdar
Format: Article
Language:English
Published: Elsevier 2016-11-01
Series:EBioMedicine
Subjects:
Gliomas
Astrocytomas
Oligodendrogliomas
SHOX2 biomarker
IDH mutation
Prognosis
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396416305011

Internet

http://www.sciencedirect.com/science/article/pii/S2352396416305011

Similar Items